Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2021

May 27, 2021

6990_dirs_2021-05-27_4c40ea0b-47d8-4eb0-ac35-3b2e679bd5af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2021-05-21

Reporting Person: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-21 Common Stock S 69838 $3.98 Disposed 3818026 Direct
2021-05-24 Common Stock S 79300 $3.83 Disposed 3738726 Direct
2021-05-25 Common stock S 261238 $3.84 Disposed 3477488 Direct

Footnotes

F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.78 to $3.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.65 to $4.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.